# Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance

> **NCT02674880** · PHASE2 · COMPLETED · sponsor: **Campus Bio-Medico University** · enrollment: 41 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** HMW-HA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02674880
- **Lead sponsor:** Campus Bio-Medico University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-01
- **Final completion:** 2019-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02674880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02674880, "Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02674880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
